United States Biotechnology & Medical Research

Kronos Bio Inc (KRON)

Track

Ticker: KRON Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kronos Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 5 Jun 2025
Value US$4,216,260.51 | Price 24.80 | Shares 19,203 (+35.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-06 2025-06-05 S Sale
KNOBELMAN DEBORAH

President & Interim CEO

Officer
19,203 +35.8%
24.80
US$4,216,261 		19,203 +35.8% 24.80 US$4,216,261
2024-07-01 2024-06-28 B Purchase
3.3
BISCHOFBERGER NORBERT W

PRESIDENT & CEO

Executive Director
6,407 -12.5%
130.28
US$1,109,256 		6,407 -12.5% 130.28 US$1,109,256
2024-07-01 2024-06-27 B Purchase
3.3
BISCHOFBERGER NORBERT W

PRESIDENT & CEO

Executive Director
89,745 -25.0%
14.25
US$3,999,683 		89,745 -25.0% 14.25 US$3,999,683
2024-06-12 2024-06-12 B Purchase
3.3
BISCHOFBERGER NORBERT W

PRESIDENT & CEO

Executive Director
881,913 +13.6%
1.24
US$1,096,041 		881,913 +13.6% 1.24 US$1,096,041
2024-06-12 2024-06-11 B Purchase
3.3
BISCHOFBERGER NORBERT W

PRESIDENT & CEO

Executive Director
744,308 +12.9%
1.09
US$814,571 		744,308 +12.9% 1.09 US$814,571
2024-06-12 2024-06-10 B Purchase
3.3
BISCHOFBERGER NORBERT W

PRESIDENT & CEO

Executive Director
1,378,901 +31.6%
0.88
US$1,208,469 		1,378,901 +31.6% 0.88 US$1,208,469
2024-02-23 2024-02-21 S Sale
1.9
Olek Elizabeth A

SR VP, CLINICAL SCIENCE

Officer
7,368 -3.7%
1.05
US$7,765 		7,368 -3.7% 1.05 US$7,765
2024-02-23 2024-02-21 S Sale
1.9
Frisbee Allison

SR VP, CORP OPERATIONS & LEGAL

Officer
12,105 -5.6%
1.05
US$12,757 		12,105 -5.6% 1.05 US$12,757
2024-02-23 2024-02-21 S Sale
1.9
Lin Charles Y

SR VP, RESEARCH & DEVELOPMENT

Officer
12,036 -4.9%
1.05
US$12,685 		12,036 -4.9% 1.05 US$12,685
2024-01-05 2024-01-04 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
7,366 -2.7%
1.18
US$8,718 		7,366 -2.7% 1.18 US$8,718
2024-01-05 2024-01-04 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
12,009 -3.7%
1.18
US$14,214 		12,009 -3.7% 1.18 US$14,214
2024-01-05 2024-01-04 S Sale
2.4
Kosacz Barbara

COO & General Counsel

Officer
10,676 -1.1%
1.18
US$12,636 		10,676 -1.1% 1.18 US$12,636
2023-12-13 2023-12-12 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
10,032 -3.6%
1.31
US$13,092 		10,032 -3.6% 1.31 US$13,092
2023-12-13 2023-12-12 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
17,367 -5.0%
1.31
US$22,664 		17,367 -5.0% 1.31 US$22,664
2023-11-17 2023-11-17 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
97,935 +4.0%
1.08
US$106,162 		97,935 +4.0% 1.08 US$106,162
2023-11-17 2023-11-16 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
262,433 +12.0%
1.00
US$261,514 		262,433 +12.0% 1.00 US$261,514
2023-11-17 2023-11-15 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
1,370,688 +169.3%
0.80
US$1,102,718 		1,370,688 +169.3% 0.80 US$1,102,718
2023-07-07 2023-07-06 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
6,634 -2.3%
1.75
US$11,625 		6,634 -2.3% 1.75 US$11,625
2023-07-07 2023-07-06 S Sale
3.6
Al-Wakeel Yasir B.

Chief Financial Officer

Officer
9,617 -2.7%
1.75
US$16,852 		9,617 -2.7% 1.75 US$16,852
2023-07-07 2023-07-06 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
10,818 -3.0%
1.75
US$18,956 		10,818 -3.0% 1.75 US$18,956
2023-02-24 2023-02-24 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
10,153 -2.8%
1.74
US$17,621 		10,153 -2.8% 1.74 US$17,621
2023-02-24 2023-02-24 S Sale
3.6
Al-Wakeel Yasir B.

Chief Financial Officer

Officer
9,026 -2.5%
1.74
US$15,665 		9,026 -2.5% 1.74 US$15,665
2023-02-24 2023-02-24 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
6,291 -2.2%
1.74
US$10,918 		6,291 -2.2% 1.74 US$10,918
2022-12-14 2022-12-12 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
9,138 -5.3%
1.81
US$16,496 		9,138 -5.3% 1.81 US$16,496
2022-12-14 2022-12-12 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
18,657 -7.8%
1.81
US$33,680 		18,657 -7.8% 1.81 US$33,680
2022-05-19 2022-05-19 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
300,000 +58.9%
3.78
US$1,134,510 		300,000 +58.9% 3.78 US$1,134,510
2022-05-19 2022-05-18 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
206,198 +68.0%
3.72
US$768,046 		206,198 +68.0% 3.72 US$768,046
2022-05-19 2022-05-17 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
90,931 +42.8%
3.83
US$348,529 		90,931 +42.8% 3.83 US$348,529
2021-12-15 2021-12-13 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
250 -0.2%
12.82
US$3,206 		250 -0.2% 12.82 US$3,206
2021-12-15 2021-12-13 S Sale
4.1
DiMartino Jorge

Chief Medical Officer & VP

Officer
16,152 -12.1%
12.36
US$199,687 		16,152 -12.1% 12.36 US$199,687
2021-12-15 2021-12-13 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
174 -0.2%
12.82
US$2,231 		174 -0.2% 12.82 US$2,231
2021-12-15 2021-12-13 S Sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
11,212 -11.6%
12.36
US$138,614 		11,212 -11.6% 12.36 US$138,614
2021-12-08 2021-12-06 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
14,356 +7.2%
12.09
US$173,492 		14,356 +7.2% 12.09 US$173,492
2021-12-02 2021-12-01 B Purchase
3.5
De Backer Marianne
Non-Executive Director
1,150 +71.9%
11.57
US$13,306 		1,150 +71.9% 11.57 US$13,306
2021-10-04 2021-10-04 PlS Planned sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
9,189 -8.7%
20.81
US$191,195 		9,189 -8.7% 20.81 US$191,195
2021-08-03 2021-08-02 PlS Planned sale
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
9,189 -8.7%
20.59
US$189,165 		9,189 -8.7% 20.59 US$189,165
2021-04-20 2021-04-20 PlS Planned sale
Loven Jakob
Non-Executive Director
19 -0.0%
20.63
US$392 		19 -0.0% 20.63 US$392
2021-04-20 2021-04-20 PlS Planned sale
Loven Jakob
Non-Executive Director
21,532 -1.6%
20.10
US$432,793 		21,532 -1.6% 20.10 US$432,793
2021-04-20 2021-04-19 PlS Planned sale
Loven Jakob
Non-Executive Director
4,157 -0.3%
21.38
US$88,877 		4,157 -0.3% 21.38 US$88,877
2021-04-20 2021-04-19 PlS Planned sale
Loven Jakob
Non-Executive Director
9,847 -0.7%
20.25
US$199,402 		9,847 -0.7% 20.25 US$199,402
2021-04-20 2021-04-16 PlS Planned sale
Loven Jakob
Non-Executive Director
7,870 -0.6%
21.56
US$169,677 		7,870 -0.6% 21.56 US$169,677
2021-04-20 2021-04-16 PlS Planned sale
Loven Jakob
Non-Executive Director
25,292 -1.8%
20.84
US$527,085 		25,292 -1.8% 20.84 US$527,085
2021-04-15 2021-04-15 PlS Planned sale
Loven Jakob
Non-Executive Director
24,818 -1.8%
21.78
US$540,536 		24,818 -1.8% 21.78 US$540,536
2021-04-15 2021-04-14 PlS Planned sale
Loven Jakob
Non-Executive Director
18,938 -1.3%
23.10
US$437,468 		18,938 -1.3% 23.10 US$437,468
2021-04-15 2021-04-14 PlS Planned sale
Loven Jakob
Non-Executive Director
13,698 -1.0%
22.38
US$306,561 		13,698 -1.0% 22.38 US$306,561
2021-04-15 2021-04-13 PlS Planned sale
Loven Jakob
Non-Executive Director
1,285 -0.1%
25.18
US$32,356 		1,285 -0.1% 25.18 US$32,356
2021-04-15 2021-04-13 PlS Planned sale
Loven Jakob
Non-Executive Director
5,738 -0.4%
24.40
US$140,007 		5,738 -0.4% 24.40 US$140,007
2021-04-15 2021-04-13 PlS Planned sale
Loven Jakob
Non-Executive Director
9,997 -0.7%
23.35
US$233,430 		9,997 -0.7% 23.35 US$233,430
2020-10-16 2020-10-14 B Purchase
0.8
MARTIN JOHN C
Non-Executive Director
75,800 +4.0%
19.00
US$1,440,200 		75,800 +4.0% 19.00 US$1,440,200
2020-10-16 2020-10-14 B Purchase
Stampacchia Otello
Non-Executive Director Large shareholder
450,000 +13.4%
19.00
US$8,550,000 		450,000 +13.4% 19.00 US$8,550,000
2020-10-16 2020-10-14 B Purchase
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust
Large shareholder
95,500 +2.2%
19.00
US$1,814,500 		95,500 +2.2% 19.00 US$1,814,500
2020-10-16 2020-10-14 B Purchase
4.2
Omega Fund V, L.P.
Large shareholder
450,000 +13.4%
19.00
US$8,550,000 		450,000 +13.4% 19.00 US$8,550,000
2020-10-16 2020-10-14 B Purchase
3.3
BISCHOFBERGER NORBERT W

President & CEO

Executive Director
95,500 +2.2%
19.00
US$1,814,500 		95,500 +2.2% 19.00 US$1,814,500
2020-10-16 2020-10-14 B Purchase
3.6
Al-Wakeel Yasir B.

Chief Financial Officer

Officer
5,250 +16.4%
19.00
US$99,750 		5,250 +16.4% 19.00 US$99,750
2020-10-16 2020-10-14 B Purchase
4.1
Dinsmore Christopher

Chief Scientific Officer

Officer
5,250 +inf%
19.00
US$99,750 		5,250 +inf% 19.00 US$99,750
2020-10-16 2020-10-14 B Purchase
2.4
Kosacz Barbara

COO & General Counsel

Officer
5,250 +0.9%
19.00
US$99,750 		5,250 +0.9% 19.00 US$99,750
2020-10-16 2020-10-14 B Purchase
3.9
Ridloff Elena
Non-Executive Director
2,630 +inf%
19.00
US$49,970 		2,630 +inf% 19.00 US$49,970
Explore more

More insider trading research around Kronos Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America